Ghent University Hospital

Ghent, Belgium


Purpose

to help generate data on safety, reactogenicity and impact of using a monovalent type-2 IPV formulation to facilitate the polio eradication program and its endgame.

Division

Global Development

Date

July 2013

Region Served

GLOBAL

Committed amount

$557,071

Grant topic

Polio

Duration (months)

17

Grantee location

Ghent, Belgium

Related work

Polio

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.